F4, a collagen XIX-derived peptide, inhibits tumor angiogenesis through αvβ3 and α5β1 integrin interaction.
Angiogenesis Inhibitors
/ pharmacology
Animals
Antineoplastic Agents
/ pharmacology
Cell Line, Tumor
Cell Movement
/ drug effects
Cell Proliferation
/ drug effects
Collagen
/ metabolism
Endothelial Cells
/ metabolism
Humans
Integrin alpha5beta1
/ drug effects
Integrin alphaVbeta3
/ drug effects
Neovascularization, Pathologic
/ drug therapy
Peptide Fragments
/ metabolism
Rats
Rats, Sprague-Dawley
Extracellular matrix
angiogenesis
collagen XIX
integrin
matrikine
Journal
Cell adhesion & migration
ISSN: 1933-6926
Titre abrégé: Cell Adh Migr
Pays: United States
ID NLM: 101469464
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
entrez:
26
7
2021
pubmed:
27
7
2021
medline:
15
12
2021
Statut:
ppublish
Résumé
We previously demonstrated that F4 peptide (CNPEDCLYPVSHAHQR) from collagen XIX was able to inhibit melanoma cell migration
Identifiants
pubmed: 34308743
doi: 10.1080/19336918.2021.1951425
pmc: PMC8312610
doi:
Substances chimiques
Angiogenesis Inhibitors
0
Antineoplastic Agents
0
Integrin alpha5beta1
0
Integrin alphaVbeta3
0
Peptide Fragments
0
Collagen
9007-34-5
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
215-223Références
Int J Cancer. 2016 Aug 15;139(4):729-35
pubmed: 26934471
J Res Med Sci. 2017 Oct 31;22:117
pubmed: 29184575
Oncotarget. 2016 Jan 12;7(2):1516-28
pubmed: 26621838
Proc Natl Acad Sci U S A. 2016 May 24;113(21):5910-5
pubmed: 27162342
Microcirculation. 2008 Nov;15(8):715-38
pubmed: 18608994
Semin Cancer Biol. 2009 Oct;19(5):329-37
pubmed: 19482086
Cold Spring Harb Perspect Biol. 2011 Jan 01;3(1):a004978
pubmed: 21421911
Int J Mol Sci. 2016 Nov 01;17(11):
pubmed: 27809279
Annu Rev Med. 2006;57:1-18
pubmed: 16409133
Nat Rev Cancer. 2003 Jun;3(6):401-10
pubmed: 12778130
Nature. 2000 Sep 14;407(6801):249-57
pubmed: 11001068
Anticancer Res. 2016 Mar;36(3):1119-26
pubmed: 26977007
Drug Discov Today. 2015 Jan;20(1):122-8
pubmed: 25450771
Genes Cancer. 2010 Jan;1(1):12-25
pubmed: 21779425
J Clin Invest. 2013 Aug;123(8):3190-200
pubmed: 23908119
Eur J Dermatol. 2010 Nov-Dec;20(6):712-8
pubmed: 20840910
Int J Cancer. 2010 Mar 1;126(5):1055-66
pubmed: 19551865
J Soc Biol. 1999;193(4-5):423-8
pubmed: 10689625
Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13767-72
pubmed: 16162671
J Biomed Sci. 2017 Mar 21;24(1):21
pubmed: 28320393
Nat Med. 2011 Nov 07;17(11):1359-70
pubmed: 22064426
Cell Tissue Res. 2010 Jan;339(1):269-80
pubmed: 19693543
Amino Acids. 1999;16(3-4):345-79
pubmed: 10399020
J Cell Biol. 2016 Mar 14;212(6):721-36
pubmed: 26975851
Oncotarget. 2015 Feb 28;6(6):3656-68
pubmed: 25668817
Drugs. 2014 Oct;74(16):1891-1925
pubmed: 25315029
Nat Rev Cancer. 2008 Aug;8(8):604-17
pubmed: 18497750
Cell Mol Life Sci. 2010 Sep;67(17):2879-95
pubmed: 20428923
J Biol Chem. 2019 Mar 29;294(13):5105-5120
pubmed: 30700553
Matrix Biol. 2001 Sep;20(5-6):337-45
pubmed: 11566268
Biochim Biophys Acta. 2014 Aug;1840(8):2589-98
pubmed: 24406397
Nat Protoc. 2011 Dec 22;7(1):89-104
pubmed: 22193302
Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006502
pubmed: 22762016
Mol Cancer Ther. 2007 Feb;6(2):506-14
pubmed: 17308049
Front Pharmacol. 2016 Feb 04;7:11
pubmed: 26869928
Exp Dermatol. 2011 Jul;20(7):605-13
pubmed: 21692861
Int J Clin Oncol. 2016 Apr;21(2):206-212
pubmed: 26879652
Lymphat Res Biol. 2008;6(3-4):155-63
pubmed: 19093788